Papers
44
Total Citations
2,543
H-Index
22
About
Douglas S. Scherr is a urologic oncologist whose career has been defined by pioneering work in minimally invasive surgery for bladder cancer, particularly the development and evaluation of robot-assisted radical cystectomy (RARC). As a leading figure in the International Robotic Cystectomy Consortium, Scherr has systematically compared robotic and open surgical approaches across perioperative outcomes, oncological efficacy, complication profiles, and long-term survival, producing landmark studies that have collectively shaped modern surgical practice. His 2007 prospective comparison of robotic versus open cystectomy (270 citations) was among the earliest rigorous evaluations of this emerging technique, while subsequent consortium analyses examining complications (225 citations) and long-term oncologic outcomes (174 citations) helped establish the evidence base that clinicians rely on today. Scherr also advanced understanding of urinary diversion strategies, comparing intracorporeal and extracorporeal reconstruction with over 300 combined citations across two major studies. His health economics work further demonstrated RARC's cost-effectiveness and national impact. With top papers collectively exceeding 1,800 citations, Scherr's contributions have profoundly influenced how bladder cancer surgery is performed and evaluated worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2A Comparison of Postoperative Complications in Open versus Robotic Cystectomy297 citations · 2009
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10